ArticleClinical and molecular hepatology2020

Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?

Jeong Su Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.